Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.

The Journal of infectious diseases - 15 Aug 2011

Taiwo Babafemi, Gallien Sebastien, Aga Evgenia, Ribaudo Heather, Haubrich Richard, Kuritzkes Daniel R, Eron Joseph J

Abstract excerpt

Population sequencing was performed for persons identified with persistent low-level viremia in 2 clinical trials. Persistent low-level viremia (defined as plasma HIV-1 RNA level >50 and <1000 copies/mL in at least 2 determinations over a 24-week period, after at least 24 weeks of antiretroviral therapy) was observed in 65 (5.6%) of 1158 patients at risk. New resistance mutations were detected during persistent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to HIV-1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV/AIDS drug development and treatment

Share to HIV/AIDS Research and Interventions

Share to HIV Infections

Share to HIV Research and Treatment

Share to Mutation

Share to Viremia

Source

Open in PubMed Open full text

Identifiers

PMID: 21791652
DOI: 10.1093/infdis/jir353
PMCID: PMC3203388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.PMID 21791652Read ↗

Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.Semantic proximity Read ↗

Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Semantic proximity Read ↗

Improved viral suppression after treatment optimization in HIV-infected patients with persistent low-level viremia.Semantic proximity Read ↗

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.Semantic proximity Read ↗

Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level ViremiaSemantic proximity Read ↗

Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART.Semantic proximity Read ↗

The HIV Virologic Outcomes of Different Interventions Among Treatment-Experienced Patients With 2 Consecutive Detectable Low-Level Viremia.Semantic proximity Read ↗

HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in ChinaSemantic proximity Read ↗

Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia.Semantic proximity Read ↗

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.Semantic proximity Read ↗

High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda.Semantic proximity Read ↗

Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.